|
Activery is feeding its pipeline with a number of different products for the use in differentiated generics or as a simple but effective way of managing your product Life Cycle Management (LCM). A product patent regarding amorphous drug combinations was submitted in April 2008 Activery intents to submit at least two further product patents within 2008 ![]() Further, Activery is committed to continuous improvement and innovation of its core technology to ensure even wider applicability of its ASP platform and the generation of even better medicines. Activery submitted its new ASP process patent in October 2007 Activery has plans to submit another technology patent within 2008 ASP is the ideal technology platform to
|
|
|
|
Products and Projects